JP Morgan bullish on six Big Biotechs, rates nine others neutral or lower (NASDAQ:INSM)

monsitj

JP Morgan said it was bullish on Insmed (NASDAQ:INSM), Denali (NASDAQ:DNLI), Immunocore (NASDAQ:IMCR), Crinetics (NASDAQ:CRNX), Mirum (NASDAQ:MIRM) and BioCryst (NASDAQ:BCRX), rating all six as overweight in a recent note that reinstated ratings for fifteen large cap biotech stocks.

The investmentCEREALKSNVCRDCPHSTOKESPRAMRNEBSNKTR

BigBiotechsBullishMorganNASDAQINSMNeutralrates
Comments (0)
Add Comment